These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 19922107)
21. Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma. Kuku I; Bayraktar MR; Kaya E; Erkurt MA; Bayraktar N; Cikim K; Aydogdu I Mediators Inflamm; 2005 Aug; 2005(3):171-4. PubMed ID: 16106104 [TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma. Mizutani Y; Matsubara H; Yamamoto K; Nan Li Y; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T Cancer; 2004 Oct; 101(8):1794-802. PubMed ID: 15386310 [TBL] [Abstract][Full Text] [Related]
23. [Studies on the relationship between the level of cytokine and liver function in patients with clonorchiasis sinensis]. Cai LS; Xiao JY; Xin H; Zhu LX; Chen G; Zhang T; Wang GZ Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Feb; 22(1):54-6. PubMed ID: 15283270 [TBL] [Abstract][Full Text] [Related]
24. [Soluble receptors of cytokines in sera of patients with systemic sclerosis--clinical correlation]. Lis AD; Brzezińska-Wcisło LA Wiad Lek; 2003; 56(11-12):532-6. PubMed ID: 15058159 [TBL] [Abstract][Full Text] [Related]
25. Serum soluble interleukin 2 receptor alpha and soluble CD8 levels in patients with gynecological malignancies undergoing radiotherapy. Frydecka I; Rusiecka M; Kuliczkowski K; Kornafel J Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):123-6. PubMed ID: 8915516 [TBL] [Abstract][Full Text] [Related]
26. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases. Shaarawy M; Darwish NA; Abdel-Aziz O J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806 [TBL] [Abstract][Full Text] [Related]
27. [Usefulness of the measurement of serum soluble IL-2 receptor alpha chain levels in clinical monitoring of non-Hodgkin lymphoma]. Setoyama Y; Imai J; Ishikawa T; Sakaida H; Takaori-Kondo A; Kawamata S; Uchiyama T Rinsho Byori; 1994 Aug; 42(8):834-42. PubMed ID: 7933620 [TBL] [Abstract][Full Text] [Related]
28. Interleukins, TNF-alpha and beta-2M in patients with B cell chronic lymphocytic leukemia. Mavridis AK; Tsiara S; Makis A; Chaidos A; Christou L; Seferiadis K; Bourantas KL J Exp Clin Cancer Res; 1998 Dec; 17(4):445-8. PubMed ID: 10089066 [TBL] [Abstract][Full Text] [Related]
29. The soluble interleukin-2 receptor--a marker for squamous cell carcinoma of the upper aerodigestive tract. Gottschlich S; Görögh T; Lippert BM; Niemann AM; Folz BJ; Werner JA Anticancer Res; 1997; 17(4B):2921-2. PubMed ID: 9329564 [TBL] [Abstract][Full Text] [Related]
30. Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid. Elsässer-Beile U; Kölble N; Grussenmeyer T; Wetterauer U; Schultze-Seemann W Anticancer Res; 1998; 18(3B):1883-90. PubMed ID: 9677439 [TBL] [Abstract][Full Text] [Related]
31. [Observation of soluble interleukin-2 receptor(sIL-2R) and tumor necrosis factor(TNF) in patients with malignant tumors of salivary gland]. Yang YH; Fu QH Shanghai Kou Qiang Yi Xue; 1999 Jun; 8(2):80-1. PubMed ID: 15048274 [TBL] [Abstract][Full Text] [Related]
32. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis. Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359 [TBL] [Abstract][Full Text] [Related]
33. [Influence of tumor-associated macrophages on progression and prognosis of nasopharyngeal carcinoma]. Peng J; Ding T; Zheng LM; Shao JY Ai Zheng; 2006 Nov; 25(11):1340-5. PubMed ID: 17094898 [TBL] [Abstract][Full Text] [Related]
34. [Significance of soluble interleukin-2 receptor alpha chain in the management of patients with malignant lymphoma: a multi-center study]. Ohno H; Ishikawa T; Kitajima H; Nomura S; Suzuki T; Konishi H; Ohno Y; Onishi R; Konaka Y; Arima N; Doi S; Nasu K; Takahashi T; Tsudo M; Fukuhara S; Uchiyama T Rinsho Ketsueki; 2002 Mar; 43(3):170-5. PubMed ID: 11979748 [TBL] [Abstract][Full Text] [Related]
35. [Level and significance of the soluble interleukin-2 receptor expression in serum of patients with bladder cancer]. Wen R; Xie S; Ma P Zhonghua Wai Ke Za Zhi; 1996 Jan; 34(1):16-8. PubMed ID: 9275680 [TBL] [Abstract][Full Text] [Related]
36. Prognostic relevance of soluble interleukin-2 receptors in patients with ovarian tumors. Gebauer G; Rieger M; Jäger W; Lang N Anticancer Res; 1999; 19(4A):2509-11. PubMed ID: 10470184 [TBL] [Abstract][Full Text] [Related]
37. Clinical significance of serum soluble interleukin 2 receptor-alpha in esophageal squamous cell carcinoma. Wang LS; Chow KC; Li WY; Liu CC; Wu YC; Huang MH Clin Cancer Res; 2000 Apr; 6(4):1445-51. PubMed ID: 10778976 [TBL] [Abstract][Full Text] [Related]
38. Soluble interleukin-2 receptors in patients with nasopharyngeal carcinoma. Lai KN; Ho S; Leung JC; Tsao SY Cancer; 1991 Apr; 67(8):2180-5. PubMed ID: 1848475 [TBL] [Abstract][Full Text] [Related]
39. [The dynamic study of cytokines pre- and postoperation in patients with carcinoma of larynx]. Wang Q; Feng Y; Zhang X; Wang H; Xu D Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Jun; 15(6):255-7. PubMed ID: 12541774 [TBL] [Abstract][Full Text] [Related]
40. Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis. Kart L; Buyukoglan H; Tekin IO; Altin R; Senturk Z; Gulmez I; Demir R; Ozesmi M Mediators Inflamm; 2003 Feb; 12(1):9-14. PubMed ID: 12745543 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]